Abstracts of Third Tehran Hepatitis Congress


ACCEPTED AS ORAL PRESENTATION

  1. EVALUATION OF HCV INFECTION IN MULTI TRANSFUSED THALASSEMIC PATIENTS AND TRACE BACKING OF THE NEW CASES ADULT THALASSEMIA CLINIC, TEHRAN

  2. THE PREVALENCE OF HEPATITIS B ANTIGEN-POSITIVITY IN THE GENERAL POPULATION OF MASHHAD, IRAN

  3. OCCULT HEPATITIS C VIRUS INFECTION IN IRANIAN PATIENTS WITH CHRONIC LIVER DISEASE WITH UNKNOWN ETIOLOGY

  4. BURDEN OF HCC IN IRAN

  5. TREATMENT OF HEPATITIS B VIRUS (HBV) RELATED LIVER CIRRHOSIS

  6. WHEN TO TREAT SUBJECTS WITH MINIMALLY ACTIVE CHRONIC HBV?

  7. BLOOD SAFETY IN IRAN, 2004-2009

  8. ACUTE HEPATITIS B

  9. SHORTER COURSE OF TREATMENT FOR HEPATITS C PATIENTS

  10. AN IRANIAN INTERNATIONAL STUDY IN INTERFERON EXPERIENCES

  11. SAFETY AND EFFICACY OF RIBAVIRIN FOR TREATMENT OF THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION; A CONTROLLED CLINICAL TRIAL OF 280 CASES

  12. PEGINTERFERON A-2A AND RIBAVIRIN TREATMENT OF PATIENTS WITH HAEMOPHILIA AND HEPATITIS C VIRUS INFECTION: A SINGLE-CENTER STUDY OF 367 CASES

  13. HEPATITIS B VIRUS GENOME DIVERSITY IN THE BASAL CORE PROMOTER REGION

  14. PEGINTERFERON FOR THE TREATMENT OF CHRONIC HEPATITIS B

  15. DRUG-INDUCED LIVER INJURY

  16. ALPHA 1 ANTITRYPSIN DEFICIENCY: MOLECULAR AND CELLULAR ASPECTS

  17. ROLE OF AUTOPHAGY IN HCV AND HBV: A POSSIBLE NEW THERAPEUTIC APPROACH

  18. AUTOIMMUNE HEPATITIS IN CHILDREN

  19. HEPATITIS B AND HEPATITIS C EPIDEMIOLOGY IN FARS PROVINCE, 2009

  20. MOLECULAR EPIDEMIOLOGY STUDY AND GENOTYPES OF HBV IN IRANIAN POPULATIONS; A NATIONAL BASED SURVEY

  21. VIRAL HEPATITIS C IN UAE

  22. IRANIAN EXPERIENCE WITH CHRONIC HEPATITIS DELTA MANAGEMENT: A PRELIMINARY REPORT

  23. MOLECULAR DIAGNOSIS OF HEPATITIS B AND HEPATITIS C VIRUSES

  24. EFFICACY OF HEPATITIS B VACCINATION IN PRISONERS: A COMPARISON OF ACCELERATED VS. CLASSIC VACCINATION PROTOCOLS

  25. PREVENTIVE MEASURES IN VIRAL HEPATITIS

  26. THE GLOBAL BURDEN OF HEPATITIS C

  27. PREPAREDNESS FOR EPIDEMICS

  28. HEPATITIS B AND C IN DIALYSIS UNITS IN IRAN

  29. HCV INFECTION IN PATIENTS WITH PERSISTENTLY NORMAL SERUM AMINOTRANSFERASES (PNALT)

  30. APPLICATION OF EUS IN LIVER DISEASE

  31. THE EMERGING CHALLENGE OF HBV REACTIVATION WITH IMMUNOSUPPRESSIVE THERAPIES

  32. CURRENT EPIDEMIOLOGY AND CLINICAL FEATURES OF HEPATITIS D IN EUROPE AND ASIA

  33. CHRONIC HEPATITIS C: MANAGEMENT OF NON-RESPONDERS AND RELAPSERS

  34. THE ROLE OF MICRORNAS IN LIVER DISEASES: A BRILLIANT NEW ATTITUDE TOWARDS DIAGNOSIS AND TREATMENT

  35. LIVER TRANSPLANTATION FOR INHERITED METABOLIC DISORDERS OF THE LIVER

  36. LIVER TRANSPLANTATION IN IRAN: A 15 YEAR EXPERIENCE

  37. MOLECULAR TARGETS AND IMMUNOLOGICAL PATHWAYS OF CHRONIC HBV INFECTION

  38. EXPECTATIONS FOR CURATIVE ANTI-HBV TREATMENT AND HCC PREVENTION

  39. MOLECULAR RESISTANCE OF HBV-INFECTED PATIENTS: IRANIAN EXPERIENCES

  40. HEPATITIS C VIRUS(HCV) TESTING FOR DIAGNOSIS AND INTERPRETATION OF RESULTS

  41. ACUTE HEPATITIS A IS ASSOCIATED WITH A MULTISPECIFIC CD8+ T CELL RESPONSE IN HLA-A2 POSITIVE PATIENTS

  42. THERAPEUTIC VACCINATION IN CHRONIC HEPATITIS B: PRECLINICAL STUDIES IN THE WOODCHUCK

  43. THE LATEST TREATMENT OPTIONS FOR CHILDREN WITH HEPATITIS C

  44. PREVENTION OF HEPATITIS B IN HEMODIALYSIS PATIENTS

  45. BURDEN, MODE OF TRANSMISSION AND TREATMENT RESPONSES OF HEPATITIS C IN PAKISTAN

  46. IRON OVERLOAD AND RESPONSE TO ANTI-HCV THERAPY IN PATIENTS WITH CHRONIC HCV

  47. EPIDEMIOLOGY OF HEPATITIS B IN IRAN: NEW APPROACH

  48. EPIDEMIOLOGY OF HEPATITIS C INFECTION IN IRAN AND THE REGION: LESSONS SHOULD BE LEARNED

  49. MANAGEMENT OF HEPATITIS B: TREATMENT OPTIONS AND RESISTANCE ISSUES

  50. OCCULT HEPATITIS B IN BLOOD DONORS: TRANSMISSION CONCERNS

  51. EPIDEMIOLOGY OF HDV IN I.R. IRAN

  52. TREATMENT RESPONSE OF CHRONIC HEPATITIS C PATIENTS IN PAKISTAN

  53. WILL HEPATITIS E VIRUS BECOME AN EMERGING INFECTIOUS DISEASE?

  54. APPLICATIONS OF MOLECULAR TESTS IN SERODISCORDANT VIRAL HEPATITIS B-INFECTED PATIENTS

  55. CLINICAL TREATMENT AND MANAGEMENT OF CHRONIC HEPATITIS B

  56. HEPATITIS C VIRUS INFECTION AND KIDNEY TRANSPLANTATION: TREATMENT


ACCEPTED AS POSTER PRESENTATION

  1. META-ANALYSIS; COMPARATIVE EFFICACY AND SAFETY OF PEGINTERFERON ALPHA-2A VS. 2B FOR TREATMENT OF CHRONIC HCV INFECTION

  2. THE RELATIONSHIP BETWEEN LIPID PROFILE AND SEVERITY OF LIVER DAMAGE IN CIRRHOTIC PATIENTS ADMITTED INTO A REFERAL HOSPITAL IN QOM, CENTRAL Iran, During 2005 to 2008

  3. ASSOCIATION OF EXON 9 BUT NOT INTRON 8 VDR POLYMORPHISMS WITH OCCULT HBV INFECTION IN SOUTH-EASTERN IRANIAN PATIENTS

  4. SERUM LEVELS OF INTERLEUKIN (IL)-10 AND IL-17A IN OCCULT HBV INFECTED SOUTH-EAST IRANIAN PATIENTS

  5. DECREASED EXPRESSION OF CCR5 ON THE PERIPHERAL BLOOD CD8+ T CELLS IN OCCULT HEPATITIS B INFECTED PATIENTS

  6. EVALUATION OF CCR5 EXPRESSION ON NK CELLS IN IRANIAN PATIENTS WITH OCCULT HEPATITIS B INFECTION

  7. COMMON HBV GENOTYPE IN SOUTH-EASTERN IRANIAN PATIENTS

  8. ARE FAS POLYMORPHISMS ASSOCIATED WITH OCCULT HBV INFECTION?

  9. HEPATITIS B VIRUS GENOTYPE, HBSAG MUTATIONS AND CO-INFECTION WITH HCV IN OCCULT HBV INFECTION

  10. ANALYSIS OF ASSOCIATION BETWEEN IL-12, IL-4 AND IFN- POLYMORPHISMS WITH OCCULT HBV INFECTION

  11. ARE FAS LIGAND POLYMORPHISMS ASSOCIATED WITH OCCULT HBV INFECTION?

  12. COMPARISON OF SERUM BETA 2-MICROGLOUBULIN( β2-MG) LEVELS IN HBSAG POSITIVE AND NEGATIVE BLOOD DONORS

  13. INFLUENCE OF HBV GENOTYPE AND GENETIC DIVERSITY ON CHRONIC HBV OUTCOME

  14. NEEDLE STICK INJURY IN NURSES: KNOWLEDGE, PRACTICE AND EXPOSURE TO HEPATITIS B

  15. PREVALENCE OF HEPATITIS C IN PREGNANT WOMEN OF LOW SOCIOECONOMIC AREA OF KARACHI

  16. WHAT ARE HEPATITIS B INFECTED PERSON PROBLEMS IN THE COMMUNITY?

  17. KNOWLEDGE AND ATTITUDE OF HEALTH CARE PROFESSIONALS' TOWARD CARING FOR PEOPLE WITH HEPATITIS C

  18. THE FREQUENCY OF SYMPTOMS OF AUTOIMMUNE HEPATITIS IN ADMITTED PATIENTS OF GI WARD OF RAZI HOSPITAL FROM APRIL 2006 TO APRIL 2009

  19. THE SURVEY OF THYROID FUNCTION TESTS IN HEPATITIS B AND C INDUCED CIRRHOSIS IN PATIENTS

  20. PRELIMINARY REPORT OF HDV GENOTYPES IN IRAN

  21. PREVALENCE OF HEPATITIS C AND B VIRUS INFECTION IN LYMPHOPROLIFERATIVE DISORDERS PATIENTS

  22. CONVENTIONAL VERSUS PEGYLATED INTERFERONS IN TREATMENT OF HCV PATIENTS

  23. EPIDEMIOLOGY OF VIRAL HEPATITIS C IN ARMENIA

  24. CLINICAL ASPECTS OF CHRONIC HCV-INFECTION IN ARMENIA

  25. SEROPREVALENCE OF HEPATITIS E VIRUS INFECTION IN URBAN AREA OF GUILAN PROVINCE

  26. HEPATITIS A VIRUS INFECTION IN MILITARY FORCES OF THE WORLD

  27. OCCULT B HEPATITIS INFECTION

  28. ALUMINUM SALTS IN RECOMBINANT HEPATITIS B VACCINE.

  29. A CASE-CONTROL STUDY OF HEPATITIS B, C, AND D IN HEMODIALYSIS PATIENTS IN DIFFERENT PROVINCES OF IRAN

  30. CLONING AND EXPRESSION OF NS3 HELICASE FRAGMENT OF HEPATITIS C VIRUS IN "PET102/D-TOPO" EXPRESSION VECTOR

  31. A POPULATION-BASE SURVEY OF PAST HEPATITIS A INFECTIONS AMONG ADULTS OF URBAN AREA IN NORTH OF IRAN - 2009.

  32. COELIAC DISEASE IN CHRONIC LIVER DISEASES

  33. CORRELATES OF HEPATITIS C AND B VIRUS INFECTIONS AMONG INJECTING DRUG USERS IN TEHRAN, IRAN

  34. OUTCOME IN PEDIATRIC AUTOIMMUNE HEPATITIS

  35. INVESTIGATION OF THE EFFECTS OF CHLORELLA VULGARIS SUPPLEMENTATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CLINICAL TRIAL

  36. CHARACTERIZATION OF DRUG-RELATED MUTATIONS IN HEPATITIS B VIRUS PARTIAL REVERSE TRANSCRIPTASE SEQUENCES IN TREATMENT-NAÏVE IRANIAN PATIENTS

  37. THE PREVALENCE RATE AND RISK FACTOR OF HEPATITIS C IN SHIRAZ BLOOD DONORS IN 2007

  38. PREVALENCE OF COMMON TYPES OF HEPATITIS C VIRUS GENOTYPES AND THE RELATION BETWEEN AGE, SEX AND TRANSMISSION RISK FACTORS IN KERMAN , IRAN

  39. COMPARATIVE STUDY OF HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH HEPATITIS C AND HEALTHY PEOPLE AND PRESENT A STRUCTURAL MODEL

  40. DENTAL TREATMENT AS A RISK FACTOR FOR HEPATITIS B AND C VIRAL INFECTION: A SYSTEMATIC REVIEW

  41. ROLE OF CELLULAR TUBULIN AND VIRAL NUCLEOCAPSID PROTEIN INTERACTIONS IN HEPATITIS C VIRUS INFECTION

  42. LONG TERM EFFICACY OF COMBINATION LAMIVUDINE AND ADEFOVIR IN PATIENTS WITH CHRONIC HEPATITIS B

  43. STUDY OF PREVALENCE OF TRANSMITTED VIRAL INFECTIONS IN REGULAR AND NON-REGULAR DONORS OF YAZD BLOOD CENTER IN 1378-1388

  44. COMPARISON OF TWO COMMERCIAL SCREENING ASSAYS FOR DIAGNOSIS OF HEPATITIS B SURFACE ANTIGEN

  45. COMPARISON OF TWO COMMERCIAL SCREENING ASSAYS FOR DIAGNOSIS OF HEPATITIS C

  46. THE EFFECTS OF CYNARA SCOLYMUS L. LEAF AND CICHORIUM INTYBUS L. ROOT EXTRACTS ON CARBON TETRACHLORIDE INDUCED LIVER TOXICITY IN RATS

  47. SEROPREVALENCE OF HEPATITIS B,C AND HIV INFECTIONS IN YAZD BLOOD DONORS

  48. SEROEPIDEMIOLOGIC ASSESSMENT OF HEPATITIS E VIRUS IN PREGNANT WOMEN, GORGAN